1-10 of 10
Jian Zhao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT081: Neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) vs chemo in Chinese patients (pts) with resectable NSCLC in CheckMate 816

Changli Wang, Ke-Neng Chen, Qixun Chen, Lin Wu, Qun Wang, Xiaofei Li, Kejing Ying, Wenxiang Wang, Jian Zhao, Lunxu Liu, Junke Fu, Chunfang Zhang, Jichun Liu, Yi Hu, Mark M. Awad, Ives Ntambwe, Junliang Cai, Judith Bushong, Phuong Tran, Shun Lu
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT081.
https://doi.org/10.1158/1538-7445.AM2023-CT081
Published: 14 April 2023
View article titled, Abstract CT081: Neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) vs chemo in Chinese patients (pts) with resectable NSCLC in CheckMate 816
Journal Articles

Abstract CT038: Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage SCLC: A phase 3 trial

Ying Cheng, Jie Wang, Caicun Zhou, Wenxiu Yao, Qiming Wang, Xuhong Min, Gongyan Chen, Xingxiang Xu, Xingya Li, Fei Xu, Yong Fang, Runxiang Yang, Guohua Yu, Youling Gong, Jun Zhao, Yun Fan, Quan Liu, Lejie Cao, Yu Yao, Yunpeng Liu, Xiaoling Li, Jingxun Wu, Zhiyong He, Kaihua Lu, Liyan Jiang, Huiqing Yu, Chengping Hu, Wenhua Zhao, Jian Zhao, Gang Wu, Dingzhi Huang, Chengshui Chen, Cuimin Ding, Baihong Zhang, Xiuwen Wang, Hui Luo, Baolan Li, Ben Zhang, Haowen Li, Ke Ma
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT038.
https://doi.org/10.1158/1538-7445.AM2022-CT038
Published: 15 June 2022
View article titled, Abstract CT038: Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage SCLC: A phase 3 trial
Journal Articles

Abstract 1896: The genomic features of Chinese cancer patients harboring HLA LOH

Jian Zhao, Jie Hu, Xiuqin Zhang, Xuan Gao, Fan Tong, Xiaorui Fu, Yuting Yi, Yanfang Guan, Xuefeng Xia, Jian'an Huang
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1896.
https://doi.org/10.1158/1538-7445.AM2021-1896
Published: 01 July 2021
View article titled, Abstract 1896: The genomic features of Chinese cancer patients harboring HLA LOH
Journal Articles

Intracellular Osteopontin Inhibits Toll-like Receptor Signaling and Impedes Liver Carcinogenesis

Xiaoyu Fan, Chunyan He, Wei Jing, Xuyu Zhou, Rui Chen, Lei Cao, Minhui Zhu, Rongjie Jia, Hao Wang, Yajun Guo, Jian Zhao
Journal: Cancer Research
Cancer Res (2015) 75 (1): 86–97.
https://doi.org/10.1158/0008-5472.CAN-14-0615
Published: 04 January 2015
View article titled, Intracellular Osteopontin Inhibits Toll-like Receptor Signaling and Impedes Liver Carcinogenesis
Open the PDF for Intracellular Osteopontin Inhibits Toll-like Receptor Signaling and Impedes Liver Carcinogenesis in another window
Includes: Supplementary data
Journal Articles

Abstract 4949: Epigenetic silence of ASPP1 and ASPP2 genes promotes tumor growth in HBV-positive hepatocellular carcinoma

Jian Zhao, Yajun Guo
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4949.
https://doi.org/10.1158/1538-7445.AM10-4949
Published: 15 April 2010
View article titled, Abstract 4949: Epigenetic silence of <em>ASPP1</em> and <em>ASPP2</em> genes promotes tumor growth in HBV-positive hepatocellular carcinoma
Journal Articles

TIP30 Induces Apoptosis under Oxidative Stress through Stabilization of p53 Messenger RNA in Human Hepatocellular Carcinoma

Jian Zhao, Jingjing Chen, Bin Lu, Li Dong, Huajing Wang, Chongshan Bi, Guobin Wu, Huaizu Guo, Mengchao Wu, Yajun Guo
Journal: Cancer Research
Cancer Res (2008) 68 (11): 4133–4141.
https://doi.org/10.1158/0008-5472.CAN-08-0432
Published: 02 June 2008
View article titled, TIP30 Induces Apoptosis under Oxidative Stress through Stabilization of <em>p53</em> Messenger RNA in Human Hepatocellular Carcinoma
Open the PDF for TIP30 Induces Apoptosis under Oxidative Stress through Stabilization of <em>p53</em> Messenger RNA in Human Hepatocellular Carcinoma in another window
Journal Articles

Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells

Huafeng Wei, Hao Wang, Bing Lu, Bohua Li, Sheng Hou, Weizhu Qian, Kexing Fan, Jianxin Dai, Jian Zhao, Yajun Guo
Journal: Cancer Research
Cancer Res (2008) 68 (10): 3854–3862.
https://doi.org/10.1158/0008-5472.CAN-07-6051
Published: 15 May 2008
View article titled, Cancer Immunotherapy Using <em>In vitro</em> Genetically Modified Targeted Dendritic Cells
Open the PDF for Cancer Immunotherapy Using <em>In vitro</em> Genetically Modified Targeted Dendritic Cells in another window
Includes: Supplementary data
Journal Articles

Development of Novel Tetravalent Anti-CD20 Antibodies with Potent Antitumor Activity

Bohua Li, Shu Shi, Weizhu Qian, Lei Zhao, Dapeng Zhang, Sheng Hou, Lei Zheng, Jianxin Dai, Jian Zhao, Hao Wang, Yajun Guo
Journal: Cancer Research
Cancer Res (2008) 68 (7): 2400–2408.
https://doi.org/10.1158/0008-5472.CAN-07-6663
Published: 01 April 2008
View article titled, Development of Novel Tetravalent Anti-CD20 Antibodies with Potent Antitumor Activity
Open the PDF for Development of Novel Tetravalent Anti-CD20 Antibodies with Potent Antitumor Activity in another window
Journal Articles

TIP30 acts as a tumor suppressor in hepatocarcinogenesis

Chao Jiang, Mitsuhiro Ito, Kristy Krumm, Xia Zhang, Jill Pecha, Jian Zhao, Yajun Guo, Robert Roeder, Hua Xiao
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1282–1283.
Published: 01 April 2004
View article titled, TIP30 acts as a tumor suppressor in hepatocarcinogenesis
Journal Articles

TIP30 Deficiency Increases Susceptibility to Tumorigenesis

Mitsuhiro Ito, Chao Jiang, Kristy Krumm, Xia Zhang, Jill Pecha, Jian Zhao, Yajun Guo, Robert G. Roeder, Hua Xiao
Journal: Cancer Research
Cancer Res (2003) 63 (24): 8763–8767.
Published: 24 December 2003
View article titled, TIP30 Deficiency Increases Susceptibility to Tumorigenesis
Open the PDF for TIP30 Deficiency Increases Susceptibility to Tumorigenesis in another window